Provention bio announces appointment of rita jain, m.d., to board of directors

Red bank, n.j. , jan. 5, 2023 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of rita jain, m.d.

PRVB Ratings Summary

PRVB Quant Ranking